Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Evolocumab |
| Synonyms | |
| Therapy Description |
Evolocumab is a monoclonal antibody that targets PCSK9, potentially leading to decreased tumor growth (PMID: 33177715). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Evolocumab | AMG 145|AMG-145|AMG145|Repatha | Evolocumab is a monoclonal antibody that targets PCSK9, potentially leading to decreased tumor growth (PMID: 33177715). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|